- Home
- CATO vs VIGL Comparison
CATO vs VIGL Comparison
Compare CATO & VIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CATO
- VIGL
- Stock Information
- Founded
- CATO 1946
- VIGL 2020
- Country
- CATO United States
- VIGL United States
- Employees
- CATO N/A
- VIGL N/A
- Industry
- CATO Clothing/Shoe/Accessory Stores
- VIGL Biotechnology: Pharmaceutical Preparations
- Sector
- CATO Consumer Discretionary
- VIGL Health Care
- Exchange
- CATO Nasdaq
- VIGL Nasdaq
- Market Cap
- CATO 63.9M
- VIGL 74.7M
- IPO Year
- CATO N/A
- VIGL 2022
- Fundamental
- Price
- CATO $2.58
- VIGL $2.42
- Analyst Decision
- CATO
- VIGL Strong Buy
- Analyst Count
- CATO 0
- VIGL 5
- Target Price
- CATO N/A
- VIGL $16.33
- AVG Volume (30 Days)
- CATO 43.3K
- VIGL 155.0K
- Earning Date
- CATO 05-22-2025
- VIGL 05-07-2025
- Dividend Yield
- CATO 13.33%
- VIGL N/A
- EPS Growth
- CATO N/A
- VIGL N/A
- EPS
- CATO N/A
- VIGL N/A
- Revenue
- CATO $649,806,000.00
- VIGL N/A
- Revenue This Year
- CATO N/A
- VIGL N/A
- Revenue Next Year
- CATO N/A
- VIGL N/A
- P/E Ratio
- CATO N/A
- VIGL N/A
- Revenue Growth
- CATO N/A
- VIGL N/A
- 52 Week Low
- CATO $2.19
- VIGL $1.31
- 52 Week High
- CATO $6.70
- VIGL $6.06
- Technical
- Relative Strength Index (RSI)
- CATO 51.00
- VIGL 60.31
- Support Level
- CATO $2.20
- VIGL $2.28
- Resistance Level
- CATO $2.56
- VIGL $3.00
- Average True Range (ATR)
- CATO 0.18
- VIGL 0.27
- MACD
- CATO 0.05
- VIGL 0.06
- Stochastic Oscillator
- CATO 92.68
- VIGL 55.38
About CATO Cato Corporation (The)
The Cato Corp operates as a specialty retailer of fashion apparel and accessories primarily in the southeastern United States. Its primary objective is to be the fashion specialty retailer for fashion and value in its markets. The company operates through the following business segments: Retail and Credit. The Retail segment which generates the majority of revenue offers fashion specialty stores. The Credit segment involves credit card services.
About VIGL Vigil Neuroscience Inc.
Vigil Neuroscience Inc is a clinical-stage biotechnology company engaged in improving the lives of patients, caregivers, and families affected by rare and common neurodegenerative diseases by pursuing the development of disease-modifying therapeutics to restore the vigilance of microglia. Microglia are the sentinel immune cells of the brain and play a critical role in maintaining central nervous system (CNS) health and responding to damage caused by disease. The group provides solutions for fully human monoclonal antibody and Oral small molecule TERM2 agonist.